Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment

por Nishihori, Taiga, Song, Jinming, Shain, Kenneth H.
Publicado 2016

MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas

por Wang, Michelle Y., Li, Tao, Ren, Yuan, Shah, Bijal D., Lwin, Tint, Gao, Jing, Shain, Kenneth H., Zhang, Wei, Zhao, Xiaohong, Tao, Jianguo
Publicado 2021

Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma

por Kareem, Syeda Saba, Viswanathan, Neena, Sahebjam, Solmaz, Tran, Nam D, Gatewood, Tyra, Tobon, Katherine, Baz, Rachid, Piña, Yolanda, Shain, Kenneth H, Mokhtari, Sepideh
Publicado 2022

Oprozomib in patients with newly diagnosed multiple myeloma

por Hari, Parameswaran, Matous, Jeffrey V., Voorhees, Peter M., Shain, Kenneth H., Obreja, Mihaela, Frye, John, Fujii, Hisaki, Jakubowiak, Andrzej J., Rossi, Davide, Sonneveld, Pieter
Publicado 2019

Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors

por Turner, Joel G., Dawson, Jana L., Grant, Steven, Shain, Kenneth H., Dalton, William S., Dai, Yun, Meads, Mark, Baz, Rachid, Kauffman, Michael, Shacham, Sharon, Sullivan, Daniel M.
Publicado 2016

XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myel...

por Turner, Joel G., Kashyap, Trinayan, Dawson, Jana L., Gomez, Juan, Bauer, Alexis A., Grant, Steven, Dai, Yun, Shain, Kenneth H., Meads, Mark, Landesman, Yosef, Sullivan, Daniel M.
Publicado 2016

Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas

por Gao, Jing, Wang, Michelle Y., Ren, Yuan, Lwin, Tint, Li, Tao, Yan, Joy C., Sotomayor, Eduardo M., Duckett, Derek R., Shah, Bijal D., Shain, Kenneth H., Zhao, Xiaohong, Tao, Jianguo
Publicado 2021

A pharmacodynamic model of clinical synergy in multiple myeloma

por Sudalagunta, Praneeth, Silva, Maria C., Canevarolo, Rafael R., Alugubelli, Raghunandan Reddy, DeAvila, Gabriel, Tungesvik, Alexandre, Perez, Lia, Gatenby, Robert, Gillies, Robert, Baz, Rachid, Meads, Mark B., Shain, Kenneth H., Silva, Ariosto S.
Publicado 2020

Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma

por Tantawy, Marwa, Yang, Guang, Algubelli, Raghunandan Reddy, DeAvila, Gabriel, Rubinstein, Samuel M., Cornell, Robert F., Fradley, Michael G., Siegel, Erin M., Hampton, Oliver A., Silva, Ariosto S., Lenihan, Daniel, Shain, Kenneth H., Baz, Rachid C., Gong, Yan
Publicado 2023

Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide

por Rollison, Dana E., Shain, Kenneth H., Lee, Ji‐Hyun, Hampras, Shalaka S., Fulp, William, Fisher, Kate, Al Ali, Najla H., Padron, Eric, Lancet, Jeffrey, Xu, Qiang, Olesnyckyj, Martha, Kenvin, Laurie, Knight, Robert, Dalton, William, List, Alan, Komrokji, Rami S.
Publicado 2016

Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma

por Hasipek, Metis, Grabowski, Dale, Guan, Yihong, Alugubelli, Raghunandan Reddy, Tiwari, Anand D., Gu, Xiaorong, DeAvila, Gabriel A., Silva, Ariosto S., Meads, Mark B., Parker, Yvonne, Lindner, Daniel J., Saunthararajah, Yogen, Shain, Kenneth H., Maciejewski, Jaroslaw P., Reu, Frederic J., Phillips, James G., Jha, Babal K.
Publicado 2021

Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma

por Peres, Lauren C., Colin-Leitzinger, Christelle M., Teng, Mingxiang, Dutil, Julie, Alugubelli, Raghunandan R., DeAvila, Gabriel, Teer, Jamie K., Du, Dongliang, Mo, Qianxing, Siegel, Erin M., Hampton, Oliver A., Alsina, Melissa, Brayer, Jason, Blue, Brandon, Baz, Rachid, Silva, Ariosto S., Nishihori, Taiga, Shain, Kenneth H., Gillis, Nancy
Publicado 2022

Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma

por Zhao, Xiaohong, Wang, Michelle Y., Jiang, Huijuan, Lwin, Tint, Park, Paul M., Gao, Jing, Meads, Mark B., Ren, Yuan, Li, Tao, Sun, Jiao, Fahmi, Naima Ahmed, Singh, Satishkumar, Sehgal, Lalit, Wang, Xuefeng, Silva, Ariosto S., Sotomayor, Eduardo M., Shain, Kenneth H., Cleveland, John L., Wang, Michael, Zhang, Wei, Qi, Jun, Shah, Bijal D., Tao, Jianguo
Publicado 2021

Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel

por Oswald, Laura B., Gudenkauf, Lisa M., Li, Xiaoyin, De Avila, Gabriel, Peres, Lauren C., Kirtane, Kedar, Gonzalez, Brian D., Hoogland, Aasha I., Nguyen, Oanh, Rodriguez, Yvelise, Baz, Rachid C., Shain, Kenneth H., Alsina, Melissa, Locke, Frederick L., Freeman, Ciara, Castaneda Puglianini, Omar, Nishihori, Taiga, Liu, Hien, Blue, Brandon, Grajales-Cruz, Ariel, Jim, Heather S. L., Hansen, Doris K.
Publicado 2023

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

por Zhao, Xiaohong, Lwin, Tint, Silva, Ariosto, Shah, Bijal, Tao, Jiangchuan, Fang, Bin, Zhang, Liang, Fu, Kai, Bi, Chengfeng, Li, Jiannong, Jiang, Huijuan, Meads, Mark B., Jacobson, Timothy, Silva, Maria, Distler, Allison, Darville, Lancia, Zhang, Ling, Han, Ying, Rebatchouk, Dmitri, Di Liberto, Maurizio, Moscinski, Lynn C., Koomen, John M., Dalton, William S., Shain, Kenneth H., Wang, Michael, Sotomayor, Eduardo, Tao, Jianguo
Publicado 2017

CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma

por Burger, Karen L., Fernandez, Mario R., Meads, Mark B., Sudalagunta, Praneeth, Oliveira, Paula S., Renatino Canevarolo, Rafael, Alugubelli, Raghunandan Reddy, Tungsevik, Alexandre, De Avila, Gabe, Silva, Maria, Graeter, Allison I., Dai, Hongyue A., Vincelette, Nicole D., Prabhu, Antony, Magaletti, Dario, Yang, Chunying, Li, Weimin, Kulkarni, Amit, Hampton, Oliver, Koomen, John M., Roush, William R., Monastyrskyi, Andrii, Berglund, Anders E., Silva, Ariosto S., Cleveland, John L., Shain, Kenneth H.
Publicado 2023

Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma

por Lee, Dae Hyun, Kumar, Abhishek, Mohammed, Turab, Peres, Lauren C., Alsina, Melissa, Bachmeier, Christina, Blue, Brandon J., Brayer, Jason, Chandrasekhar, Sanjay, Grajales Cruz, Ariel, De Avila, Gabe, Elmariah, Hany, Faramand, Rawan, Freeman, Ciara, Jain, Michael, Khadka, Sushmita, Khimani, Farhad, Liu, Hien, Nishihori, Taiga, Oswald, Laura B., Castaneda Puglianini, Omar A., Shain, Kenneth H., Smith, Eric, Baz, Rachid C., Locke, Frederick L., Oliveira, Guilherme H., Alomar, Mohammed, Hansen, Doris K.
Publicado 2023

Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma

por Mostofa, AGM, Distler, Allison, Meads, Mark B., Sahakian, Eva, Powers, John J., Achille, Alexandra, Noyes, David, Wright, Gabriela, Fang, Bin, Izumi, Victoria, Koomen, John, Rampakrishnan, Rupal, Nguyen, Tuan P., De Avila, Gabriel, Silva, Ariosto S., Sudalagunta, Praneeth, Canevarolo, Rafael Renatino, Siqueira Silva, Maria D. Coelho, Alugubelli, Raghunandan Reddy, Dai, Hongyue A., Kulkarni, Amit, Dalton, William S., Hampton, Oliver A., Welsh, Eric A., Teer, Jamie K., Tungesvik, Alexandre, Wright, Kenneth L., Pinilla-Ibarz, Javier, Sotomayor, Eduardo M., Shain, Kenneth H., Brayer, Jason
Publicado 2021

Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease

por Mason, Mike J., Schinke, Carolina, Eng, Christine L. P., Towfic, Fadi, Gruber, Fred, Dervan, Andrew, White, Brian S., Pratapa, Aditya, Guan, Yuanfang, Chen, Hongjie, Cui, Yi, Li, Bailiang, Yu, Thomas, Chaibub Neto, Elias, Mavrommatis, Konstantinos, Ortiz, Maria, Lyzogubov, Valeriy, Bisht, Kamlesh, Dai, Hongyue Y., Schmitz, Frank, Flynt, Erin, Dan Rozelle, Danziger, Samuel A., Ratushny, Alexander, Dalton, William S., Goldschmidt, Hartmut, Avet-Loiseau, Herve, Samur, Mehmet, Hayete, Boris, Sonneveld, Pieter, Shain, Kenneth H., Munshi, Nikhil, Auclair, Daniel, Hose, Dirk, Morgan, Gareth, Trotter, Matthew, Bassett, Douglas, Goke, Jonathan, Walker, Brian A., Thakurta, Anjan, Guinney, Justin
Publicado 2020

Replicative Instability Drives Cancer Progression

por Morris, Benjamin B., Smith, Jason P., Zhang, Qi, Jiang, Zhijie, Hampton, Oliver A., Churchman, Michelle L., Arnold, Susanne M., Owen, Dwight H., Gray, Jhanelle E., Dillon, Patrick M., Soliman, Hatem H., Stover, Daniel G., Colman, Howard, Chakravarti, Arnab, Shain, Kenneth H., Silva, Ariosto S., Villano, John L., Vogelbaum, Michael A., Borges, Virginia F., Akerley, Wallace L., Gentzler, Ryan D., Hall, Richard D., Matsen, Cindy B., Ulrich, C. M., Post, Andrew R., Nix, David A., Singer, Eric A., Larner, James M., Stukenberg, Peter Todd, Jones, David R., Mayo, Marty W.
Publicado 2022